URGN Competitors & Alternatives
Compare UroGen Pharma Ltd with similar stocks in the same industry
Biotechnology
URGN
Main Stock$42.31
Tradestie Score
53
Market Cap
$824.20M
Revenue Growth
2.0%
Analyst Upside
+41.8%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.20
|
$2.23B | - | 44 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.20
|
$2.22B | - | 55 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$66.17
|
$2.21B | - | 48 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$21.09
|
$2.18B | - | 45 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.48
|
$2.08B | - | 47 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$20.45
|
$2.02B | - | 34 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.74
|
$2.01B | - | 32 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$33.41
|
$1.97B | - | 54 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.49
|
$1.92B | - | 51 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$83.45
|
$1.92B | - | 39 | Compare |
More URGN Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry